As of late August, the Senate Committee on Finance had finished collecting an initial set of responses from pharmaceutical companies concerning educational grants but had not yet begun reviewing the responses; nor did it have a set timeline for finishing the review process. After going over the materials, the Committee will decide whether it will ask pharmaceutical companies for more detailed information and/or hold a hearing on the issue. As we reported in the July/August issue, in June, ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only unlock thePrinter-friendly, you'll also gain access to exclusive premium content.

Already registered? here.